UPDATE: This webinar has, due to circumstances out of our control, been postponed until 2024
Whilst we’re disappointed not to bring you a new live webinar, please follow this link to access the on-demand recording of a similar webinar hosted earlier this year, which featured Yousaf Ahmad, Chief Pharmacist, Frimley ICS; Selma Abed, Head of Medicines Optimisation, Spirit Health and Kalveer Flora, Lead Rheumatology Specialist Pharmacist, London North West University Healthcare Trust, discussing how value in medicines optimization should really be measured.
How can medicines optimisation teams drive value and collaboration across the system?
Originally scheduled for 21 November 2023
As a follow-up to the HSJ ICS Medicines Forum, we are delighted that Spirit Health will be hosting a new webinar.
Medicines optimisation looks at the value which medicines deliver, making sure they are clinically-effective and cost-effective. It is about ensuring people get the right choice of medicines, at the right time, and are engaged in the process by their clinical team. We will look at how meds op teams can:
- Improve patient outcomes
- Engage patients in their treatment and care
- Ensure patients avoid taking unnecessary medicines
- Reduce wastage of medicines
- Improve medicines safety
We will also address the workforce challenges currently facing pharmacy and prescribing and consider how key projects align with the overarching themes of the Medicines Value Programme, the Pharmacy Integration Fund and the Pharmacy Reform Programme.
The content of the webinar will be built in more detail after the Forum itself, but potential items for discussion include:
- Meds op within an ICB – where are the main pressure points and how can we resolve them?
- How can we support overstretched primary care teams to optimise medicines?
- Exploring new processes that can be implemented to streamline treatment pathways
- Ensuring effective management of all the key stakeholders
- Defining value: what does ‘value’ mean, what does it look like, and measuring value in an ICS setting
- Identifying opportunities for savings and understanding that medicines value isn’t just about saving money, but also about creating new pathways for care and treatment
- Personalised care: building trust and embedding a culture of shared decision-making where patients have access to their own records and can have input into their care
- Ensuring that your medicines optimisation strategy encompasses all the key issues around workforce, ways of working, medicines safety, value, over prescribing. What does a good MO strategy actually look like?
- How can we better integrate community pharmacy to drive value and improve the patient experience and clinical outcomes?
- Selma Abed, Head of Medicines Optimisation, Spirit Health